Shares of Vertex Pharmaceuticals Inc. VRTX, -0.62% slid 0.62% to $195.25 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +0.25% rising 0.25% to 4,447.70 and the Dow Jones Industrial Average DJIA, +0.62% rising 0.62% to 35,484.97. This was the stock’s fourth consecutive day of losses. Vertex Pharmaceuticals Inc. closed $88.20 below its 52-week high ($283.45), which the company achieved on September 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ, +0.02% rose 0.02% to $173.80, Merck & Co. Inc. MRK, +0.03% rose 0.03% to $75.21, and AbbVie Inc. ABBV, -0.96% fell 0.96% to $113.72. Trading volume (4.2 M) eclipsed its 50-day average volume of 2.5 M.